Detalhe da pesquisa
1.
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.
Cell
; 157(2): 369-381, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24703711
2.
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Blood
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805638
3.
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood
; 139(15): 2347-2354, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108372
4.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
5.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724563
6.
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.
Eur J Haematol
; 111(6): 938-945, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731314
7.
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.
Am J Hematol
; 98(12): 1847-1855, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671649
8.
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factor.
Pediatr Blood Cancer
; 70(4): e30039, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316822
9.
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
Blood
; 136(2): 224-234, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219447
10.
A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Nature
; 540(7633): 433-437, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926740
11.
miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2.
J Cell Mol Med
; 25(1): 575-585, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270982
12.
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
N Engl J Med
; 378(13): 1189-1199, 2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601269
13.
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
Blood
; 133(16): 1766-1777, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755419
14.
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
; 133(10): 1140-1151, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610028
15.
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML.
Blood
; 132(14): 1526-1534, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049810
16.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898087
17.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049642
18.
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.
Am J Hematol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769689
19.
RUNX1 germline variants in RUNX1-mutant AML: how frequent?
Blood
; 137(10): 1428-1431, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33075818
20.
MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia.
Blood
; 128(18): 2253-2257, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27574191